Incidental Mutation 'R8393:Vezt'
ID 647477
Institutional Source Beutler Lab
Gene Symbol Vezt
Ensembl Gene ENSMUSG00000036099
Gene Name vezatin, adherens junctions transmembrane protein
Synonyms
MMRRC Submission 067811-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R8393 (G1)
Quality Score 225.009
Status Not validated
Chromosome 10
Chromosomal Location 93797384-93871661 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to C at 93832704 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Threonine to Alanine at position 236 (T236A)
Ref Sequence ENSEMBL: ENSMUSP00000113715 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000047711] [ENSMUST00000118077] [ENSMUST00000118205] [ENSMUST00000119818] [ENSMUST00000123201] [ENSMUST00000141241] [ENSMUST00000150344] [ENSMUST00000150704]
AlphaFold Q3ZK22
Predicted Effect probably damaging
Transcript: ENSMUST00000047711
AA Change: T236A

PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
SMART Domains Protein: ENSMUSP00000037955
Gene: ENSMUSG00000036099
AA Change: T236A

DomainStartEndE-ValueType
low complexity region 100 117 N/A INTRINSIC
Pfam:Vezatin 149 440 1.6e-60 PFAM
low complexity region 566 581 N/A INTRINSIC
low complexity region 702 715 N/A INTRINSIC
low complexity region 764 779 N/A INTRINSIC
Predicted Effect probably damaging
Transcript: ENSMUST00000118077
AA Change: T236A

PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
SMART Domains Protein: ENSMUSP00000113983
Gene: ENSMUSG00000036099
AA Change: T236A

DomainStartEndE-ValueType
low complexity region 100 117 N/A INTRINSIC
Pfam:Vezatin 149 440 9.2e-61 PFAM
low complexity region 566 581 N/A INTRINSIC
Predicted Effect probably damaging
Transcript: ENSMUST00000118205
AA Change: T236A

PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
SMART Domains Protein: ENSMUSP00000113321
Gene: ENSMUSG00000036099
AA Change: T236A

DomainStartEndE-ValueType
low complexity region 100 117 N/A INTRINSIC
Pfam:Vezatin 149 440 1e-60 PFAM
low complexity region 566 581 N/A INTRINSIC
Predicted Effect probably damaging
Transcript: ENSMUST00000119818
AA Change: T236A

PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
SMART Domains Protein: ENSMUSP00000113715
Gene: ENSMUSG00000036099
AA Change: T236A

DomainStartEndE-ValueType
low complexity region 100 117 N/A INTRINSIC
Pfam:Vezatin 150 442 1e-93 PFAM
low complexity region 570 585 N/A INTRINSIC
low complexity region 706 719 N/A INTRINSIC
low complexity region 768 783 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000123201
SMART Domains Protein: ENSMUSP00000114550
Gene: ENSMUSG00000036099

DomainStartEndE-ValueType
low complexity region 100 117 N/A INTRINSIC
Pfam:Vezatin 120 190 2.1e-9 PFAM
Predicted Effect probably damaging
Transcript: ENSMUST00000141241
AA Change: T46A

PolyPhen 2 Score 0.997 (Sensitivity: 0.41; Specificity: 0.98)
SMART Domains Protein: ENSMUSP00000123575
Gene: ENSMUSG00000036099
AA Change: T46A

DomainStartEndE-ValueType
Pfam:Vezatin 1 97 1.2e-25 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000150344
SMART Domains Protein: ENSMUSP00000122561
Gene: ENSMUSG00000036099

DomainStartEndE-ValueType
low complexity region 120 137 N/A INTRINSIC
transmembrane domain 180 202 N/A INTRINSIC
Predicted Effect probably damaging
Transcript: ENSMUST00000150704
AA Change: T236A

PolyPhen 2 Score 0.996 (Sensitivity: 0.55; Specificity: 0.98)
SMART Domains Protein: ENSMUSP00000121727
Gene: ENSMUSG00000036099
AA Change: T236A

DomainStartEndE-ValueType
low complexity region 100 117 N/A INTRINSIC
Pfam:Vezatin 149 256 1.7e-18 PFAM
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.6%
  • 20x: 98.6%
Validation Efficiency
MGI Phenotype FUNCTION: This gene encodes a transmembrane protein that is essential for the formation of adherens junctions. It is required for both the pre-implantation morphogenesis of a blastocyst and for the implantation process. The encoded protein is also a component of the ankle-link complex in cochlear hair cells, where it may effect resilience to sound trauma. It is also thought to be involved in dendritic spine morphogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
PHENOTYPE: Mice homozygous for a null allele develop to the blastocyst stage inducing a decidual response but die at implantation. Only about half of blastocysts are able to hatch upon in vitro culture and mutant outgrowths show severe defects in intercellular adhesion and signs of cellular degeneration. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 58 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Acot11 T C 4: 106,617,390 (GRCm39) T239A probably benign Het
Adgrg7 A G 16: 56,582,477 (GRCm39) S258P probably damaging Het
Capn10 T A 1: 92,871,130 (GRCm39) D313E probably benign Het
Caprin2 A G 6: 148,770,650 (GRCm39) V448A probably benign Het
Casr A G 16: 36,330,566 (GRCm39) V256A probably benign Het
Cped1 A G 6: 22,222,465 (GRCm39) T742A possibly damaging Het
Cyp2c39 G T 19: 39,525,255 (GRCm39) R186L possibly damaging Het
Dazl A T 17: 50,588,294 (GRCm39) S294T probably benign Het
Dnah17 C A 11: 117,947,855 (GRCm39) V2982F probably damaging Het
Enpp3 C A 10: 24,702,139 (GRCm39) C71F probably damaging Het
Fam234a A G 17: 26,437,149 (GRCm39) C177R probably damaging Het
Fbxl5 A C 5: 43,925,433 (GRCm39) Y186D possibly damaging Het
Fbxo43 T C 15: 36,162,494 (GRCm39) T238A probably benign Het
Fcgbp A G 7: 27,806,815 (GRCm39) H2261R probably benign Het
Gm20939 C T 17: 95,183,207 (GRCm39) H148Y probably damaging Het
Gpat4 GTGTT GT 8: 23,669,498 (GRCm39) probably benign Het
Gpr45 C A 1: 43,071,395 (GRCm39) H13N probably benign Het
Irf4 A G 13: 30,947,610 (GRCm39) D438G probably damaging Het
Kcnk1 T C 8: 126,751,964 (GRCm39) V190A probably benign Het
Klre1 A T 6: 129,557,025 (GRCm39) K42N probably damaging Het
Lmbrd2 C T 15: 9,178,437 (GRCm39) T499M probably damaging Het
Lrrc14 G T 15: 76,598,398 (GRCm39) G345C probably damaging Het
Matn2 A G 15: 34,355,748 (GRCm39) H251R possibly damaging Het
Mpnd A G 17: 56,323,568 (GRCm39) E477G probably damaging Het
Muc17 C T 5: 137,171,179 (GRCm39) V151I Het
Nckap5l A C 15: 99,325,050 (GRCm39) C484W probably damaging Het
Npas1 C T 7: 16,195,266 (GRCm39) S354N probably damaging Het
Or1e25 T C 11: 73,494,261 (GRCm39) L285P probably damaging Het
Or4k2 C A 14: 50,424,342 (GRCm39) E112* probably null Het
Or52ab2 A T 7: 102,969,668 (GRCm39) I17F Het
Or52e3 T C 7: 102,869,399 (GRCm39) V158A probably benign Het
Or5w11 T C 2: 87,459,197 (GRCm39) L14P probably damaging Het
Or6c65 G T 10: 129,604,304 (GRCm39) *313L probably null Het
Or8d4 T A 9: 40,038,360 (GRCm39) H299L probably benign Het
Pabpc6 G A 17: 9,887,435 (GRCm39) P372L probably damaging Het
Pkd1 A G 17: 24,791,621 (GRCm39) N1103D probably damaging Het
Prelid2 C T 18: 42,014,313 (GRCm39) C171Y probably benign Het
R3hcc1 T C 14: 69,942,890 (GRCm39) Q229R probably benign Het
Rapgef6 T C 11: 54,578,487 (GRCm39) V1003A probably benign Het
Rbp3 T A 14: 33,678,156 (GRCm39) H701Q possibly damaging Het
Resf1 A T 6: 149,229,998 (GRCm39) T1015S possibly damaging Het
Rmdn2 T C 17: 79,975,459 (GRCm39) probably null Het
Robo2 A T 16: 73,775,382 (GRCm39) W451R probably damaging Het
Sacs T A 14: 61,410,655 (GRCm39) M1K probably null Het
Senp2 G A 16: 21,850,864 (GRCm39) G294R probably damaging Het
Setdb2 T A 14: 59,650,180 (GRCm39) H478L probably benign Het
Slc12a4 G T 8: 106,678,451 (GRCm39) A295E probably damaging Het
Slc12a9 C T 5: 137,319,698 (GRCm39) V606M probably damaging Het
Slc25a30 T C 14: 76,012,451 (GRCm39) K66E probably benign Het
Slc39a6 T C 18: 24,732,331 (GRCm39) E319G possibly damaging Het
Sorbs3 T A 14: 70,422,360 (GRCm39) T617S probably benign Het
Speer4a3 A T 5: 26,158,076 (GRCm39) V92E probably damaging Het
Spef2 T G 15: 9,676,615 (GRCm39) D652A probably benign Het
Stag3 T C 5: 138,295,017 (GRCm39) M347T probably damaging Het
Tecpr2 A T 12: 110,911,191 (GRCm39) D1076V probably damaging Het
Tor2a G A 2: 32,651,648 (GRCm39) V288I probably benign Het
Usp30 C T 5: 114,259,826 (GRCm39) R511* probably null Het
Zmynd12 A T 4: 119,305,352 (GRCm39) D264V probably damaging Het
Other mutations in Vezt
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01448:Vezt APN 10 93,832,719 (GRCm39) missense probably damaging 1.00
IGL01655:Vezt APN 10 93,832,859 (GRCm39) missense probably benign 0.00
IGL02014:Vezt APN 10 93,832,811 (GRCm39) missense probably benign 0.35
IGL03072:Vezt APN 10 93,809,895 (GRCm39) missense probably damaging 1.00
R0542:Vezt UTSW 10 93,842,958 (GRCm39) critical splice acceptor site probably null
R1633:Vezt UTSW 10 93,820,138 (GRCm39) missense probably damaging 1.00
R1757:Vezt UTSW 10 93,806,425 (GRCm39) missense probably benign
R1808:Vezt UTSW 10 93,826,026 (GRCm39) missense probably damaging 1.00
R4296:Vezt UTSW 10 93,809,793 (GRCm39) small deletion probably benign
R4972:Vezt UTSW 10 93,836,212 (GRCm39) critical splice donor site probably null
R5079:Vezt UTSW 10 93,856,486 (GRCm39) splice site probably null
R5137:Vezt UTSW 10 93,806,372 (GRCm39) missense probably benign 0.00
R5319:Vezt UTSW 10 93,806,193 (GRCm39) missense probably benign
R5743:Vezt UTSW 10 93,832,957 (GRCm39) missense probably benign 0.01
R6002:Vezt UTSW 10 93,836,336 (GRCm39) missense probably damaging 1.00
R6281:Vezt UTSW 10 93,809,808 (GRCm39) missense probably benign 0.04
R6652:Vezt UTSW 10 93,806,141 (GRCm39) missense probably damaging 1.00
R6681:Vezt UTSW 10 93,832,859 (GRCm39) missense probably benign 0.00
R6914:Vezt UTSW 10 93,806,313 (GRCm39) missense probably benign
R7100:Vezt UTSW 10 93,832,795 (GRCm39) missense probably benign 0.13
R7131:Vezt UTSW 10 93,806,409 (GRCm39) nonsense probably null
R7743:Vezt UTSW 10 93,816,286 (GRCm39) missense probably damaging 1.00
R8137:Vezt UTSW 10 93,775,154 (GRCm39) missense
R9006:Vezt UTSW 10 93,809,874 (GRCm39) missense probably benign
R9043:Vezt UTSW 10 93,820,027 (GRCm39) missense probably damaging 0.99
R9453:Vezt UTSW 10 93,832,856 (GRCm39) nonsense probably null
R9753:Vezt UTSW 10 93,806,183 (GRCm39) missense probably benign 0.00
Predicted Primers PCR Primer
(F):5'- GCAGATAAGCAGAACCCTACTTTAC -3'
(R):5'- GTTTCCCACGTGCTGGATTG -3'

Sequencing Primer
(F):5'- GCAGAACCCTACTTTACACCCTTC -3'
(R):5'- CCACGTGCTGGATTGTGTCC -3'
Posted On 2020-09-02